These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 35846801)

  • 41. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review.
    Bhattacharyya A; Sarma P; Sharma DJ; Das KK; Kaur H; Prajapat M; Kumar S; Bansal S; Prakash A; Avti P; Thota P; Reddy DH; Gautam BS; Medhi B
    Indian J Pharmacol; 2021; 53(4):317-327. PubMed ID: 34414911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rhino-Orbital-Cerebral Mucormycosis in a Young Diabetic Patient with COVID-19 in Ethiopia: A Case Report.
    Alemayehu FM; Abate HK; Soboka TA; Huluka DK; Worke AB; Abrie MT; Dibaba DK; Asnake YB
    Int Med Case Rep J; 2022; 15():251-257. PubMed ID: 35615254
    [TBL] [Abstract][Full Text] [Related]  

  • 43. COVID-19 associated Rhino-Orbito-Cerebral Mucormycosis: Imaging spectrum and Clinico-radiological correlation- a single Centre experience.
    Patel DD; Adke S; Badhe PV; Lamture S; Marfatia H; Mhatre P
    Clin Imaging; 2022 Feb; 82():172-178. PubMed ID: 34864270
    [TBL] [Abstract][Full Text] [Related]  

  • 44. COVID-19-related Rhino-orbital-cerebral Mucormycosis.
    Al-Ani RM; Al Tameemi KM
    Qatar Med J; 2022; 2022(4):47. PubMed ID: 36258686
    [TBL] [Abstract][Full Text] [Related]  

  • 45. C-reactive Protein Kinetics During In-Patient Treatment of COVID-19-Associated Rhino-Orbito-Cerebral Mucormycosis: A Retrospective Cohort Study in a Tertiary Hospital in Central India.
    B H S; Bidkar V; Prathipati K; Dabhekar S; Selvaraj K; G D
    Cureus; 2024 Apr; 16(4):e59007. PubMed ID: 38800245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. COVID associated mucormycosis: A preliminary study from a dedicated COVID Hospital in Delhi.
    Meher R; Wadhwa V; Kumar V; Shisha Phanbuh D; Sharma R; Singh I; Rathore PK; Goel R; Arora R; Garg S; Kumar S; Kumar J; Agarwal M; Singh M; Khurana N; Sagar T; Manchanda V; Saxena S
    Am J Otolaryngol; 2022; 43(1):103220. PubMed ID: 34547717
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
    Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
    Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The ROC Staging System for COVID-related Rhino-Orbital-Cerebral Mucormycosis.
    Naik MN; Rath S
    Semin Ophthalmol; 2022 Apr; 37(3):279-283. PubMed ID: 34260342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ophthalmic presentation and outcomes of rhino-orbito-cerebral mucormycosis during the COVID-19 pandemic: An 18-month follow-up report.
    Veisi A; Aletaha M; Abolhosseini M; Ownagh V; Fekri S; Feizi M; Amoushahi Khouzani S; Najafi M
    J Fr Ophtalmol; 2024 Mar; 47(5):104139. PubMed ID: 38696866
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially.
    Jiang N; Zhao G; Yang S; Lin J; Hu L; Che C; Wang Q; Xu Q
    BMC Ophthalmol; 2016 Jan; 16():10. PubMed ID: 26758904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A cross-sectional study to describe the spectrum of ocular manifestations and risk factors of mucormycosis presenting to a tertiary hospital of East India.
    Raj A; Nishant P; Sadhukhan K; Saha BC; Sinha U; Kokkayil P; Gupta A; Kumar A; Tiwari P
    Indian J Ophthalmol; 2023 Jan; 71(1):249-256. PubMed ID: 36588245
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical Phenotypes of COVID-19 Associated Mucormycosis (CAM): A Comprehensive Review.
    Almyroudi MP; Akinosoglou K; Rello J; Blot S; Dimopoulos G
    Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rising Incidence of Post Covid Rhinocerebral Mucormycosis: An Otolaryngologists Prospective.
    Sahni D; Singh P; Kaur R; Aggarwal S; Kaur A
    Indian J Otolaryngol Head Neck Surg; 2023 May; 75(4):1-9. PubMed ID: 37362131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. COVID-19 and Mucormycosis: A Black Fungus Disaster?
    Chillana S; Mohit Chilana KA
    Indian J Dermatol; 2022; 67(5):535-538. PubMed ID: 36865825
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Various Treatment Modalities in COVID-19 Associated Facial Mucormycosis and the Need for its Surgical Management: A Systematic Review.
    Chopra S; Setiya S; Waknis PP; Kale L; Tidke S
    J Maxillofac Oral Surg; 2023 Mar; ():1-22. PubMed ID: 37362874
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rhino-orbito-cerebral mucormycosis during Covid-19 pandemic- a prospective observational study.
    Fatima N; Ahmed S; Shameem M; Ahmed A; Hasan W; Khan PA
    Indian J Med Microbiol; 2023; 46():100467. PubMed ID: 37651764
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of Imaging Spectrum Along With Other Diagnostic Modalities in Rhino-Orbital-Cerebral Mucormycosis (ROCM).
    Meena V; Barath S; Singh S; Jakhar P; Patel T
    Cureus; 2024 Feb; 16(2):e53962. PubMed ID: 38469024
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rhino-orbito-cerebral mucormycosis in a post-COVID-19 diabetic patient: Rare case from Iran.
    Fakhar M; Sharifpour A; Zakariaei Z; Banimostafavi ES; Soleymani M; Davoodi L
    Clin Case Rep; 2022 Feb; 10(2):e05506. PubMed ID: 35237439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.
    Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S
    Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975
    [No Abstract]   [Full Text] [Related]  

  • 60. Hit or Miss: The Dilemma of Specimen Selection for Microbiological Diagnosis of Rhino-Orbital-Cerebral- COVID-Associated Mucormycosis (ROCM-CAM).
    Jain V; Aggarwal A; Shrimali T; Vishwakarma K; Paul D; Kombade SP; Sharma V; Soni K; Choudhary B; Goyal A; Chugh A; Tiwari S; Sharma DK; Agarwal A; Misra S
    Infect Disord Drug Targets; 2023; 23(1):e160822207524. PubMed ID: 35975857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.